Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rNAPc2 in second-line metastatic colorectal carcinoma
NCT00443573Phase 2Suspended
- Sponsor
- Oruka Therapeutics
- Start
- Dec 2006
- Primary completion
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant nematode anticoagulant protein c2 in colorectal cancer (CRC), sponsored by Oruka Therapeutics. Started Dec 2006; status: suspended.
02
Drugs
recombinant nematode anticoagulant protein c2
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00443573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443573.